biotech
Kamada BioPharma Limited at Fieldfisher LLP
Kamada BioPharma Limited trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.
Registry index of 1 ClinicalTrials.gov studies linked to Kamada BioPharma Limited programs — each row shows trial ID, program name, phase, status, and indication.
Kamada BioPharma Limited trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.
Latest clinical program signals indexed for Kamada BioPharma Limited.
Adult Patients with Congenital Alpha-1 Antitrypsin Deficiency with Moderate and Severe Airflow Limitation (40% ≤ FEV1 ≤ 80% of predicted; FEV1/SVC ≤ 70%), and with no history of two or more moderate or one or more severe exacerbations of COPD during the past year.